Eosinophil chemokines and chemokine receptors: Their role in eosinophil accumulation and activation in asthma and potential as therapeutic targets

Journal of Asthma

Volumn 38, Issue 8, 2001, Pages 605-613

  Menzies Gow, A ^a   Robinson, D S ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; EOTAXIN; RANTES; REACTIVE OXYGEN METABOLITE;

ASTHMA; BRONCHUS MUCOSA; CELL ACTIVATION; DEGRANULATION; DRUG TARGETING; EOSINOPHIL; HUMAN; LEUKOCYTE; PATHOPHYSIOLOGY; PROTEIN FAMILY; REVIEW;

ASTHMA; BRONCHI; CHEMOKINES; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; EOSINOPHILIA; EOSINOPHILS; HUMANS; RECEPTORS, CHEMOKINE;

EID: 0035180609     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-100107538     Document Type: Review

References (57)

1. Eosinophils and the allergic inflammatory response
2. Predominant Th2-like bronchoalveolar T lymphocyte population in atopic asthma
3. Human chemokines: An update
4. Recent advances in chemokines and chemokine receptors
5. Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation
6. Cloning of the human eosinophil chemoattractant, eotaxin
7. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes
8. Molecular cloning of the novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3
9. Eosinophil chemokines and their receptors: An attractive target in asthma?
10. Co-operation between IL-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo
11. Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis
12. Eosinophil activation by eotaxin - Eotaxin primes the production of reactive oxygen species from eosinophils
13. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines
14. Chemokines induce eosinophil degranulation through CCR3
15. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils
16. Are chemokines essential or secondary participants in allergic responses?
17. A novel human CC chemokine, eotaxin-3 which is expressed in IL-4 stimulated vascular endothelial cells, exhibits potent activity towards eosinophils
18. Eotaxin potentiates antigen-dependent basophil IL-4 production
19. Molecular cloning and characterisation of a human eotaxin receptor selectively expressed on eosinophils
20. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines
21. Eotaxin receptor, CCR3, is expressed on CD34+ progenitor cells and is upregulated following allergen-inhalation challenge in asthmatic subjects
22. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells
23. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airways hyperresponsiveness and predominant co-localisation of eotaxin mRNA to bronchial epithelial and endothelial cells
24. Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in Vivo
25. Enhanced expression of eotaxin and CCR3 in atopic dermatitis
26. CC chemokines in allergen-induced late phase cutaneous responses in atopic subjects: Association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and MCP-4 with the later 24 hour tissue eosinophilia, and relationship to basophils and other CC chemokines (MCP-3 and RANTES)
27. Activation of human eosinophil effector functions by CC chemokines
28. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and MCP-4 in human airway inflammation with eosinophilia
29. MCP-4 expression in the airways of patients with asthma
30. Differential regulation of eosinophil chemokine signalling via CCR3 and non-CCR3 pathways
31. RANTES and IL-8 induced responses in normal human eosinophils: Effects of priming with IL-5
32. The biologic role of IL-8: Functional analysis and expression of CXCR1 and CXCR2 on human eosinophils
33. Expression of CXCR4 in Eosinophils: Functional Analyses and Cytokine-Mediated Regulation
34. Chemokines and Asthma: Redundancy of Function or a Coordinated Effort?
35. Relationship between IL-5 and eotaxin in regulating blood and tissue eosinophilia in mice
36. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow
37. Increased mature and immature CCR3 messenger RNA+ eosinophils in bone marrow from patients with atopic asthma compared with atopic and non-atopic control subjects
38. Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm
39. Eotaxin and eosinophil recruitment: Implications of human disease
40. Expression of eotaxin by human lung epithelial cells
41. T-cell dependent regulation of eotaxin in antigen-induced pulmonary eosinophilia
42. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells
43. Th1-derived cytokine IFNγ is a potent inhibitor of eotaxin synthesis in vitro
44. IL-12 regulates bone marrow eosinophilia and airway eotaxin levels induced by airway allergen exposure
45. Eotaxin: An essential mediator of eosinophil trafficking into mucosal tissues
46. Increases in eotaxin-positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challenge
47. Eotaxin in induced sputum of asthmatics; relationship with eosinophils and eosinophil cationic protein in sputum
48. Elevated plasma eotaxin levels in patients with acute asthma
49. Eotaxin and impaired lung function in asthma
50. Eosinophil chemotactic chemokines and C-C chemokine receptor expression in bronchial biopsies from atopic and non-atopic asthmatics
51. CC chemokines and IL-5 in bronchial lavage fluid from patients with status asthmaticus
52. Chemokine receptor usage by human eosinophils: The importance of CCR3 demonstrated using an antagonistic monoclonal antibody
53. Identification of potent, selective non-peptide CCR3 antagonist that inhibits eotaxin, eotaxin-2 and MCP-4 induced eosinophil migration
54. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3 mediated HIV-1 entry
55. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1α and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation
56. C-C chemokine receptor 3 antagonism by the β-chemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine methionine swap
57. Targeted disruption of the chemokine eotaxin partially reduces antigen induced tissue eosinophilia